Iron in the Tumor Microenvironment-Connecting the Dots
Open accessAbstract
Iron metabolism and tumor biology are intimately linked. Iron facilitates the production of oxygen radicals, which may either result in iron-induced cell death, ferroptosis, or contribute to mutagenicity and malignant transformation. Once transformed, malignant cells require high amounts of iron for proliferation. In addition, iron has multiple regulatory effects on the immune system, thus affecting tumor surveillance by immune cells. For these reasons, inconsiderate iron supplementation in cancer patients has the potential of worsening disease course and outcome. On the other hand, chronic immune activation in the setting of malignancy alters systemic iron homeostasis and directs iron fluxes into myeloid cells. While this response aims at withdrawing iron from tumor cells, it may impair the effector functions of tumor-associated macrophages and will result in iron-restricted erythropoiesis and the development of anemia, subsequently. This review summarizes our current knowledge of the interconnections of iron homeostasis with cancer biology, discusses current clinical controversies in the treatment of anemia of cancer and focuses on the potential roles of iron in the solid tumor microenvironment, also speculating on yet unknown molecular mechanisms.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Iron can be detrimental by contributing to free radical formation, which may provoke oxidative stress and DNA damage.
“On the other hand, iron may be detrimental due to its redox abilities, thereby contributing to free radical formation, which in turn may provoke oxidative stress and DNA damage.”
From Iron as a central player and promising target in cancer progression (2019) · cites this paper as [2]
Iron-induced DNA damage and protein/lipid modifications may cause a more aggressive tumor cell behavior.
“In turn, this may cause a more aggressive tumor cell behavior [1,2,3].”
From Iron as a central player and promising target in cancer progression (2019) · cites this paper as [2]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691 · see citing works
Regulation of Ferroptotic Cancer Cell Death by GPX4
Yang, W. S., SriRamaratnam, R., Welsch, M. E., Shimada, K., Skouta, R., Viswanathan, V. S., Cheah, J. H., Clemons, P. A., Shamji, A. F., Clish, C. B., et al. (2014) · Cell · doi:10.1016/j.cell.2013.12.010 · Cited by 7,713 · see citing works
Molecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323 · see citing works
The chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534 · see citing works
Macrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335 · see citing works
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S. N., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,834 · see citing works
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803 · see citing works
Ferroptosis as a p53-mediated activity during tumour suppression
Jiang, L., Kon, N., Li, T., Wang, S.-J., Su, T., Hibshoosh, H., Baer, R., & Gu, W. (2015) · Nature · doi:10.1038/nature14344 · Cited by 3,398 · see citing works
Alternative Activation of Macrophages: An Immunologic Functional Perspective
Martinez, F. O., Helming, L., & Gordon, S. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132532 · Cited by 2,745 · see citing works
Nemeth, E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pedersen, B. K., & Ganz, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420945 · Cited by 2,650 · see citing works
Distinct role of macrophages in different tumor microenvironments
Lewis, C. E., & Pollard, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4005 · Cited by 2,225 · see citing works
Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy
Mancias, J. D., Wang, X., Gygi, S. P., Harper, J. W., & Kimmelman, A. C. (2014) · Nature · doi:10.1038/nature13148 · Cited by 2,084 · see citing works
Bingle, L., Brown, N. J., & Lewis, C. E. (2002) · The Journal of Pathology · doi:10.1002/path.1027 · Cited by 2,022 · see citing works
Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway
Viswanathan, V. S., Ryan, M. J., Dhruv, H. D., Gill, S., Eichhoff, O. M., Seashore-Ludlow, B., Kaffenberger, S. D., Eaton, J. K., Shimada, K., Aguirre, A. J., et al. (2017) · Nature · doi:10.1038/nature23007 · Cited by 2,011 · see citing works
Ferroptosis is an autophagic cell death process
Gao, M., Monian, P., Pan, Q., Zhang, W., Xiang, J., & Jiang, X. (2016) · Cell Research · doi:10.1038/cr.2016.95 · Cited by 1,899 · see citing works
VEGF as a Key Mediator of Angiogenesis in Cancer
Carmeliet, P. (2005) · Oncology · doi:10.1159/000088478 · Cited by 1,776 · see citing works
Identification of the haemoglobin scavenger receptor
Kristiansen, M., Graversen, J. H., Jacobsen, C., Sonne, O., Hoffman, H.-J., Law, S. K. A., & Moestrup, S. K. (2001) · Nature · doi:10.1038/35051594 · Cited by 1,712 · see citing works
Hypoxia, HIF1 and glucose metabolism in the solid tumour
Denko, N. C. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2468 · Cited by 1,707 · see citing works
Camaschella, C. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1401038 · Cited by 1,678 · see citing works
Iron and cancer: more ore to be mined
Torti, S. V., & Torti, F. M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3495 · Cited by 1,621 · see citing works
Inflammation meets cancer, with NF-κB as the matchmaker
Ben‐Neriah, Y., & Karin, M. (2011) · Nature Immunology · doi:10.1038/ni.2060 · Cited by 1,379 · see citing works
Dysmetabolic Hyperferritinemia: All Iron Overload Is Not Hemochromatosis
Makker, J. S., Hanif, A., Bajantri, B., & Chilimuri, S. S. (2015) · Case Reports in Gastroenterology · doi:10.1159/000373883 · Cited by 1,353 · see citing works
A Red carpet for iron metabolism
Muckenthaler, M. U., Rivella, S., Hentze, M. W., & Galy, B. (2017) · Cell · doi:10.1016/j.cell.2016.12.034 · Cited by 1,319 · see citing works
Movahedi, K., Laoui, D., Gysemans, C. A., Baeten, M., Stangé, G. M., den Bossche, J. V., Mack, M., PIPELEERS, D. G., Veld, P. I. '., BAETSELIER, P. D., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4672 · Cited by 1,229 · see citing works
Nicolas, G., Chauvet, C., Viatte, L., Danan, J. L., Bigard, X., Devaux, I., Beaumont, C., Kahn, A., & Vaulont, S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215686 · Cited by 1,214 · see citing works
Identification of erythroferrone as an erythroid regulator of iron metabolism
Kautz, L., Jung, G., Valore, E. V., Rivella, S., Nemeth, E., & Ganz, T. (2014) · Nature Genetics · doi:10.1038/ng.2996 · Cited by 1,127 · see citing works
Vulpe, C. D., Kuo, Y.-M., Murphy, T. L., Cowley, L., Askwith, C., Libina, N., Gitschier, J., & Anderson, G. J. (1999) · Nature Genetics · doi:10.1038/5979 · Cited by 1,084 · see citing works
Papanikolaou, G., & Pantopoulos, K. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.06.021 · Cited by 1,070 · see citing works
Direct Visualization of Macrophage-Assisted Tumor Cell Intravasation in Mammary Tumors
Wyckoff, J. B., Wang, Y., Lin, E. Y., Li, J.-F., Goswami, S. K., Stanley, E. R., Segall, J. E., Pollard, J. W., & Condeelis, J. S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1823 · Cited by 1,053 · see citing works
Zhang, Q., Liu, L., Gong, C., Shi, H., Zeng, Y., Wang, X., Zhao, Y., & Wei, Y.-Q. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050946 · Cited by 1,041 · see citing works
Macrophage defense mechanisms against intracellular bacteria
Weiss, G., & Schaible, U. E. (2015) · Immunological Reviews · doi:10.1111/imr.12266 · Cited by 989 · see citing works
Interleukin-6 induces hepcidin expression through STAT3
Wrighting, D. M., & Andrews, N. C. (2006) · Blood · doi:10.1182/blood-2006-06-027631 · Cited by 983 · see citing works
Mori, K., Lee, H. T., Rapoport, D., Drexler, I. R., Foster, K., Yang, J., Schmidt-Ott, K. M., Chen, X., Li, J. Y., Weiss, S., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23056 · Cited by 954 · see citing works
Anemia as an independent prognostic factor for survival in patients with cancer
Caro, J. J., Salas, M., Ward, A., & Goss, G. D. (2001) · Cancer · doi:10.1002/1097-0142(20010615)91:12 · Cited by 947 · see citing works
Schaible, U. E., & Kaufmann, S. H. E. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro1046 · Cited by 945 · see citing works
Advances in Hypoxia-Inducible Factor Biology
Choudhry, H., & Harris, A. L. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.10.005 · Cited by 873 · see citing works
High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin
Tanno, T., Bhanu, N. V., Oneal, P. A., Goh, S.-H., Staker, P., Lee, Y. T., Moroney, J. W., Reed, C. H., Luban, N. L., Wang, R.-H., et al. (2007) · Nature Medicine · doi:10.1038/nm1629 · Cited by 854 · see citing works
Jaime, J., Salas, M., Ward, A., & Goss, G. D. (2001) · PubMed · Cited by 844 · see citing works
The role of myeloid cells in cancer therapies
Engblom, C., Pfirschke, C., & Pittet, M. J. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.54 · Cited by 788 · see citing works
The Intestinal Microbiota in Colorectal Cancer.
Tilg, H., Adolph, T. E., Gerner, R. R., & Moschen, A. R. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.004 · Cited by 777 · cited 1× · see citing works
“The role of the microbiome in cancer development is increasingly appreciated (379).”
BackgroundOhgami, R. S., Campagna, D. R., Greer, E. L., Antiochos, B., McDonald, A., Chen, J., Sharp, J. J., Fujiwara, Y., Barker, J. E., & Fleming, M. D. (2005) · Nature Genetics · doi:10.1038/ng1658 · Cited by 775 · see citing works
Dowdle, W. E., Nyfeler, B., Nagel, J., Elling, R. A., Liu, S., Triantafellow, E., Menon, S., Wang, Z., Honda, A., Pardee, G., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3053 · Cited by 759 · see citing works
Goswami, S. K., Sahai, E. A., Wyckoff, J. B., Cammer, M., Cox, D., Pixley, F. J., Stanley, E. R., Segall, J. E., & Condeelis, J. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1853 · Cited by 739 · see citing works
Muckenthaler, M. U., Galy, B., & Hentze, M. W. (2008) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.28.061807.155521 · Cited by 701 · see citing works
Iron and Its Relation to Immunity and Infectious Disease
Oppenheimer, S. J. (2001) · The Journal of Nutrition · doi:10.1093/jn/131.2.616s · Cited by 695 · see citing works
The two faces of IL-6 in the tumor microenvironment
Fisher, D. T., Appenheimer, M. M., & Evans, S. S. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.01.008 · Cited by 693 · see citing works
DeNardo, D. G., & Coussens, L. M. (2007) · Breast Cancer Research · doi:10.1186/bcr1746 · Cited by 677 · see citing works
A Cell-Surface Receptor for Lipocalin 24p3 Selectively Mediates Apoptosis and Iron Uptake
Devireddy, L. R., Gazin, C., Zhu, X., & Green, M. R. (2005) · Cell · doi:10.1016/j.cell.2005.10.027 · Cited by 672 · see citing works
Pham, C. G., Bubici, C., Zazzeroni, F., Papa, S., Jones, J., Alvarez, K., Jayawardena, S., De Smaele, E., Cong, R., Beaumont, C., et al. (2004) · Cell · doi:10.1016/j.cell.2004.10.017 · Cited by 663 · see citing works
Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs)
Peyssonnaux, C., Zinkernagel, A. S., Schuepbach, R. A., Rankin, E., Vaulont, S., Haase, V. H., Nizet, V., & Johnson, R. S. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31370 · Cited by 639 · see citing works
Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis
Riabov, V., Gudima, A., Wang, N., Mickley, A., Orekhov, A. N., & Kzhyshkowska, J. G. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00075 · Cited by 631 · see citing works
Casazza, A., Laoui, D., Wenes, M., Rizzolio, S., Bassani, N., Mambretti, M., Deschoemaeker, S., Ginderachter, J. A. V., Tamagnone, L., & Mazzone, M. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.11.007 · Cited by 627 · see citing works
Jaeggi, T., Kortman, G. A. M., Moretti, D., Chassard, C., Holding, P., Dostal, A., Boekhorst, J., Timmerman, H. M., Swinkels, D. W., Tjalsma, H., et al. (2015) · Gut · doi:10.1136/gutjnl-2014-307720 · Cited by 622 · see citing works
ROS, stress‐activated kinases and stress signaling in cancer
Benhar, M., Engelberg, D., & Levitzki, A. (2002) · The EMBO Reports · doi:10.1093/embo-reports/kvf094 · Cited by 600 · see citing works
Bohlius, J., Schmidlin, K., Brillant, C., Schwarzer, G., Trelle, S., Seidenfeld, J., Zwahlen, M., Clarke, M. J., Weingart, O., Kluge, S., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60502-x · Cited by 598 · see citing works
Formation, Prevention, and Repair of DNA Damage by Iron/Hydrogen Peroxide
Henle, E. S., & Linn, S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.31.19095 · Cited by 582 · see citing works
Characterization of Heme as Activator of Toll-like Receptor 4
Figueiredo, R. T., Fernandez, P. L., Mourao-Sa, D. S., Porto, B. N., Dutra, F. F., Alves, L. S., Oliveira, M. F., Oliveira, P. L., Graça-Souza, A. V., & Bozza, M. T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610737200 · Cited by 576 · see citing works
Body Iron Stores and the Risk of Cancer
Stevens, R. G., Jones, D. Y., Micozzi, M. S., & Taylor, P. R. (1988) · New England Journal of Medicine · doi:10.1056/nejm198810203191603 · Cited by 576 · see citing works
STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation
Verga Falzacappa, M. V., Vujic Spasic, M., Kessler, R., Stolte, J., Hentze, M. W., & Muckenthaler, M. U. (2007) · Blood · doi:10.1182/blood-2006-07-033969 · Cited by 567 · see citing works
Tumor-associated macrophages: Functional diversity, clinical significance, and open questions
Biswas, S. K., Allavena, P., & Mantovani, A. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0367-7 · Cited by 551 · see citing works
Probiotic Bacteria Reduce Salmonella Typhimurium Intestinal Colonization by Competing for Iron
Deriu, E., Liu, J. Z., Pezeshki, M., Edwards, R. A., Ochoa, R. J., Contreras, H., Libby, S. J., Fang, F. C., & Raffatellu, M. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.06.007 · Cited by 550 · see citing works
Regulation of hepcidin transcription by interleukin-1 and interleukin-6
Lee, P. L., Peng, H., Gelbart, T., Wang, L., & Beutler, E. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409808102 · Cited by 542 · see citing works
A cytosolic iron chaperone that delivers iron to ferritin
Shi, H., Bencze, K. Z., Stemmler, T. L., & Philpott, C. C. (2008) · Science · doi:10.1126/science.1157643 · Cited by 536 · see citing works
Iscove, N. N., & Melchers, F. (1978) · The Journal of Experimental Medicine · doi:10.1084/jem.147.3.923 · Cited by 531 · see citing works
Zimmermann, M. B., Chassard, C., Rohner, F., N'Goran, E. K., Nindjin, C., Dostal, A., Utzinger, J., Ghattas, H., Lacroix, C., & Hurrell, R. F. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.004564 · Cited by 520 · see citing works
Chakraborty, S., Kaur, S., Guha, S., & Batra, S. K. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.03.008 · Cited by 503 · see citing works
Iron, anaemia, and inflammatory bowel diseases
Gasché, C., Lomer, M. C. E., Cavill, I., & Weiss, G. (2004) · Gut · doi:10.1136/gut.2003.035758 · Cited by 496 · see citing works
Self-citationKnutson, M. D., Oukka, M., Koss, L. M., Aydemir, F., & Wessling-Resnick, M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409409102 · Cited by 479 · see citing works
Anemia at older age: etiologies, clinical implications, and management
Stauder, R., Valent, P., & Theurl, I. (2018) · Blood · doi:10.1182/blood-2017-07-746446 · Cited by 479 · see citing works
Labile plasma iron in iron overload: redox activity and susceptibility to chelation
Esposito, B. P., Breuer, W., Sirankapracha, P., Pootrakul, P., Hershko, C., & Cabantchik, Z. I. (2003) · Blood · doi:10.1182/blood-2003-03-0807 · Cited by 475 · see citing works
Identification of the receptor scavenging hemopexin-heme complexes
Hvidberg, V., Maniecki, M. B., Jacobsen, C., Højrup, P., Møller, H. J., & Moestrup, S. K. (2005) · Blood · doi:10.1182/blood-2005-03-1185 · Cited by 473 · see citing works
KDM4/JMJD2 Histone Demethylases: Epigenetic Regulators in Cancer Cells
Berry, W. L., & Janknecht, R. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4300 · Cited by 453 · see citing works
The role of iron in cell cycle progression and the proliferation of neoplastic cells
Le, N. (2002) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(02)00068-9 · Cited by 453 · see citing works
Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathway
Cohen, L. A., Gutierrez, L., Weiss, A., Leichtmann-Bardoogo, Y., Zhang, D.-L., Crooks, D. R., Sougrat, R., Morgenstern, A., Galy, B., Hentze, M. W., et al. (2010) · Blood · doi:10.1182/blood-2009-11-253815 · Cited by 452 · see citing works
Ferroportin and Iron Regulation in Breast Cancer Progression and Prognosis
Pinnix, Z. K., Miller, L. D., Wang, W., D’Agostino, R., Kute, T., Willingham, M. C., Hatcher, H., Tesfay, L., Sui, G., Di, X., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001127 · Cited by 448 · see citing works
Gupta, N., & Wish, J. B. (2017) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2016.12.011 · Cited by 447 · see citing works
Differential regulation of iron homeostasis during human macrophage polarized activation
Recalcati, S., Locati, M., Marini, A., Santambrogio, P., Zaninotto, F., De Pizzol, M., Zammataro, L., Girelli, D., & Cairo, G. (2010) · European Journal of Immunology · doi:10.1002/eji.200939889 · Cited by 438 · see citing works
Ijssennagger, N., Belzer, C., Hooiveld, G. J. E. J., Dekker, J. P., van Mil, S. W. C., Müller, M. M., Kleerebezem, M., & van der Meer, R. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1507645112 · Cited by 436 · see citing works
Shah, Y. M., Matsubara, T., Ito, S., Yim, S.-H., & Gonzalez, F. J. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2008.12.012 · Cited by 431 · see citing works
Proinflammatory Cytokines Lowering Erythropoietin Production
JELKMANN, W. (1998) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1998.18.555 · Cited by 422 · see citing works
Theurl, I., Aigner, E., Theurl, M., Nairz, M., Seifert, M., Schroll, A., Sonnweber, T., Eberwein, L., Witcher, D. R., Murphy, A. T., et al. (2009) · Blood · doi:10.1182/blood-2008-12-195651 · Cited by 421 · see citing works
Self-citationCytokine-mediated regulation of iron transport in human monocytic cells
Ludwiczek, S., Aigner, E., Theurl, I., & Weiss, G. (2003) · Blood · doi:10.1182/blood-2002-08-2459 · Cited by 420 · see citing works
On-demand erythrocyte disposal and iron recycling requires transient macrophages in the liver
Theurl, I., Hilgendorf, I., Nairz, M., Tymoszuk, P., Haschka, D., Asshoff, M., He, S., Gerhardt, L. M. S., Holderried, T. A. W., Seifert, M., et al. (2016) · Nature Medicine · doi:10.1038/nm.4146 · Cited by 412 · see citing works
Self-citationDetection, evaluation, and management of iron-restricted erythropoiesis
Goodnough, L. T., Nemeth, E., & Ganz, T. (2010) · Blood · doi:10.1182/blood-2010-05-286260 · Cited by 410 · see citing works
Koskenkorva-Frank, T. S., Weiss, G., Koppenol, W. H., & Burckhardt, S. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.09.001 · Cited by 406 · see citing works
Distinct Roles for Intra- and Extracellular Siderophores during Aspergillus fumigatus Infection
Schrettl, M., Bignell, E., Kragl, C., Sabiha, Y., Loss, O., Eisendle, M., Wallner, A., Arst, H. N., Haynes, K., & Haas, H. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030128 · Cited by 405 · see citing works
The struggle for iron - a metal at the host-pathogen interface: Iron at the host-pathogen interface
Nairz, M., Schroll, A., Sonnweber, T., & Weiss, G. (2010) · Cellular Microbiology · doi:10.1111/j.1462-5822.2010.01529.x · Cited by 398 · see citing works
Self-citationIntravital imaging of metastatic behavior through a mammary imaging window
Kedrin, D., Gligorijevic, B., Wyckoff, J. B., Verkhusha, V. V., Condeelis, J. S., Segall, J. E., & van Rheenen, J. (2008) · Nature Methods · doi:10.1038/nmeth.1269 · Cited by 395 · see citing works
Eukaryotic DNA polymerases require an iron-sulfur cluster for the formation of active complexes
Netz, D. J. A., Stith, C. M. W., Stümpfig, M., Köpf, G., Vogel, D., Genau, H. M., Stodola, J. L., Lill, R., Burgers, P., & Pierik, A. J. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.721 · Cited by 388 · see citing works
TLR4-dependent hepcidin expression by myeloid cells in response to bacterial pathogens
Peyssonnaux, C., Zinkernagel, A. S., Datta, V., Lauth, X., Johnson, R. S., & Nizet, V. (2006) · Blood · doi:10.1182/blood-2005-06-2259 · Cited by 379 · see citing works
Lipocalin 2 protects from inflammation and Tumorigenesis associated with gut microbiota alterations
Moschen, A. R., Gerner, R. R., Wang, J., Klepsch, V., Adolph, T. E., Reider, S. J., Hackl, H., Pfister, A., Schilling, J., Moser, P. L., et al. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.03.007 · Cited by 375 · see citing works
The elemental role of iron in DNA synthesis and repair
Puig, S., Ramos-Alonso, L., Romero, A. M., & Martínez‐Pastor, M. T. (2017) · Metallomics · doi:10.1039/c7mt00116a · Cited by 364 · see citing works
Lipocalin 2 promotes breast cancer progression
Yang, J., Bielenberg, D. R., Rodig, S. J., Doiron, R., Clifton, M. C., Kung, A. L., Strong, R. K., Zurakowski, D., & Moses, M. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810617106 · Cited by 356 · see citing works
Scara5 Is a Ferritin Receptor Mediating Non-Transferrin Iron Delivery
Li, J. Y., Paragas, N., Ned, R. M., Qiu, A., Viltard, M., Leete, T., Drexler, I. R., Chen, X., Sanna‐Cherchi, S., Mohammed, F., et al. (2009) · Developmental Cell · doi:10.1016/j.devcel.2008.12.002 · Cited by 355 · see citing works
Hemolysis-induced lethality involves inflammasome activation by heme
Dutra, F. F., Alves, L. S., Rodrigues, D., Fernandez, P. L., de Oliveira, R. B., Golenbock, D. T., Zamboni, D. S., & Bozza, M. T. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1405023111 · Cited by 353 · see citing works
Hvidberg, V., Jacobsen, C. B., Strong, R. K., Cowland, J. B., Moestrup, S. K., & Borregaard, N. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.12.031 · Cited by 351 · see citing works
Iron Metabolism in the Reticuloendothelial System
Knutson, M. D., & Wessling‐Resnick, M. (2003) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/713609210 · Cited by 349 · see citing works
Umemura, N., Saio, M., Suwa, T., Kitoh, Y., Bai, J., Nonaka, K., Ouyang, G., Okada, M., Balázs, M., Ádány, R., et al. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0907611 · Cited by 347 · see citing works
Hypoxic regulation of erythropoiesis and iron metabolism
Haase, V. H. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00174.2010 · Cited by 347 · see citing works
The Transferrin Receptor Modulates Hfe-Dependent Regulation of Hepcidin Expression
Schmidt, P. J., Toran, P. T., Giannetti, A. M., Bjorkman, P. J., & Andrews, N. C. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.11.016 · Cited by 345 · see citing works
Iron overloaded polarizes macrophage to proinflammation phenotype through ROS /acetyl‐p53 pathway
Zhou, Y., Que, K., Zhang, Z., Yi, Z. J., Zhao, P., You, Y., Gong, J., & Liu, Z. (2018) · Cancer Medicine · doi:10.1002/cam4.1670 · Cited by 337 · see citing works
Brines, M. L., & Cerami, A. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.02024.x · Cited by 333 · see citing works
Iron at the interface of immunity and infection
Nairz, M., Haschka, D., Demetz, E., & Weiss, G. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00152 · Cited by 325 · see citing works
Self-citationAschemeyer, S., Qiao, B., Stefanova, D., Valore, E. V., Sek, A. C., Ruwe, T. A., Vieth, K. R., Jung, G., Casu, C., Rivella, S., et al. (2018) · Blood · doi:10.1182/blood-2017-05-786590 · Cited by 325 · see citing works
Wang, L., Chang, J., Varghese, D., Dellinger, M. T., Kumar, S., Best, A. M., Ruiz, J. C., Bruick, R. K., Peña‐Llopis, S., Xu, J., et al. (2013) · Nature Communications · doi:10.1038/ncomms3035 · Cited by 320 · see citing works
Iron and immunity: a double-edged sword.
Weiss, G. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.0320s1070.x · Cited by 317 · see citing works
Self-citationSTAT3 Is Required for IL-6-gp130–Dependent Activation of Hepcidin In Vivo
Pietrangelo, A., Dierssen, U., Valli, L., Garuti, C., Rump, A., Corradini, E., Ernst, M., Klein, C., & Trautwein, C. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.10.018 · Cited by 315 · see citing works
Body iron stores and risk of cancer
Knekt, P., Reunanen, A., Takkunen, H., Aromaa, A., Heliövaara, M., & Hakuunen, T. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910560315 · Cited by 314 · see citing works
Iron trafficking and metabolism in macrophages: contribution to the polarized phenotype.
Cairo, G., Recalcati, S., Mantovani, A., & Locati, M. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.03.007 · Cited by 312 · cited 1× · see citing works
“TAMs display a strongly M2-polarized phenotype in most types of malignancies and are ascribed such “iron-donating” features that may contribute to their tumor-promoting properties (323).”
BackgroundER Stress Controls Iron Metabolism Through Induction of Hepcidin
Vecchi, C., Montosi, G., Zhang, K., Lamberti, I., Duncan, S. A., Kaufman, R. J., & Pietrangelo, A. (2009) · Science · doi:10.1126/science.1176639 · Cited by 310 · see citing works
Lactoferrin in a Context of Inflammation-Induced Pathology
Kruzel, M. L., Zimecki, M., & Actor, J. K. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01438 · Cited by 308 · see citing works
Iron traffics in circulation bound to a siderocalin (Ngal)–catechol complex
Bao, G., Clifton, M., Hoette, T. M., Mori, K., Deng, S.-X., Qiu, A., Viltard, M., Williams, D., Paragas, N., Leete, T., et al. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.402 · Cited by 307 · see citing works
Oexle, H., Gnaiger, E., & Weiss, G. (1999) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(99)00088-2 · Cited by 307 · see citing works
Migrating into the tumor: a roadmap for T cells
van der Woude, L. L., Gorris, M. A. J., Halilovic, A., Figdor, C. G., & de Vries, I. J. M. (2017) · Trends in cancer · doi:10.1016/j.trecan.2017.09.006 · Cited by 307 · see citing works
JMJD5 regulates PKM2 nuclear translocation and reprograms HIF-1α–mediated glucose metabolism
Wang, H., Hsieh, Y., Cheng, W.-C., Lin, C.-P., Lin, Y.-S., Yang, S.-F., Chen, C.-C., Izumiya, Y., Yu, J., Kung, H.-J., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1311249111 · Cited by 306 · see citing works
Safran, M., Kim, W. Y., O'Connell, F., Flippin, L., Günzler, V., Horner, J. W., DePinho, R. A., & Kaelin, W. G. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509459103 · Cited by 305 · see citing works
Zacharski, L. R., Chow, B. K., Howes, P. S., Shamayeva, G., Baron, J. A., Dalman, R. L., Malenka, D. J., Ozaki, C. K., & Lavori, P. W. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn209 · Cited by 304 · see citing works
MRI of Tumor-Associated Macrophages with Clinically Applicable Iron Oxide Nanoparticles
Daldrup-Link, H. E., Golovko, D. M., Ruffell, B., DeNardo, D. G., Castaneda, R., Ansari, C., Rao, J., Tikhomirov, G. A., Wendland, M. F., Corot, C., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3420 · Cited by 302 · see citing works
Essential functions of iron-requiring proteins in DNA replication, repair and cell cycle control
Zhang, C. (2014) · Protein & Cell · doi:10.1007/s13238-014-0083-7 · Cited by 299 · see citing works
Ruddell, R. G., Hoang‐Le, D., Barwood, J. M., Rutherford, P. S., Piva, T. J., Watters, D. J., Santambrogio, P., Arosio, P., & Ramm, G. A. (2009) · Hepatology · doi:10.1002/hep.22716 · Cited by 298 · see citing works
Marro, S., Chiabrando, D., Messana, E., Stolte, J., Turco, E., Tolosano, E., & Muckenthaler, M. U. (2010) · Haematologica · doi:10.3324/haematol.2009.020123 · Cited by 297 · see citing works
Devireddy, L. R., Hart, D. O., Goetz, D. H., & Green, M. R. (2010) · Cell · doi:10.1016/j.cell.2010.04.040 · Cited by 295 · see citing works
Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines
Aapro, M., Beguin, Y. P., Bokemeyer, C., Dicato, M. A., Gascón, P., Glaspy, J. A., Hofmann, A., Link, H., Littlewood, T. J., Ludwig, H., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx758 · Cited by 293 · see citing works
Evstatiev, R., & Gasché, C. (2011) · Gut · doi:10.1136/gut.2010.214312 · Cited by 292 · see citing works
Redox signaling and cancer: The role of “labile” iron
Galaris, D., Skiada, V., & Barbouti, A. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.02.038 · Cited by 284 · see citing works
A missense mutation in TFRC, encoding transferrin receptor 1, causes combined immunodeficiency
Jabara, H. H., Boyden, S. E., Chou, J., Ramesh, N., Massaad, M. J., Benson, H., Bainter, W., Fraulino, D., Rahimov, F., Sieff, C., et al. (2016) · Nature Genetics · doi:10.1038/ng.3465 · Cited by 279 · see citing works
Vascular niche IL-6 induces alternative macrophage activation in glioblastoma through HIF-2α
Wang, Q., He, Z., Huang, M., Liu, T., Wang, Y., Xu, H., Duan, H., Ma, P., Zhang, L., Zamvil, S. S., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03050-0 · Cited by 279 · see citing works
Mazurier, J., & Spik, G. (1980) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(80)90112-9 · Cited by 278 · see citing works
Moderate elevation of body iron level and increased risk of cancer occurrence and death
Stevens, R. G., Graubard, B. I., Micozzi, M. S., Neriishi, K., & Blumberg, B. S. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910560312 · Cited by 276 · see citing works
Paganini, D., & Zimmermann, M. B. (2017) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.117.156067 · Cited by 262 · see citing works
Concepts of blood transfusion in adults
Goodnough, L. T., Levy, J. H., & Murphy, M. F. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60650-9 · Cited by 261 · see citing works
Ludwig, H., Müldür, E., Endler, G., & Hübl, W. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt118 · Cited by 261 · see citing works
Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents
Richardson, D. R., Kalinowski, D. S., Lau, S. L., Jansson, P. J., & Lovejoy, D. B. (2008) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.04.003 · Cited by 260 · see citing works
Chen, Z., Zhang, D., Yue, F., Zheng, M., Kovačević, Ž., & Richardson, D. R. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.350470 · Cited by 250 · see citing works
The significance of ferritin in cancer: Anti-oxidation, inflammation and tumorigenesis
Alkhateeb, A. A., & Connor, J. R. (2013) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2013.07.002 · Cited by 247 · see citing works
Mammalian Tissue Oxygen Levels Modulate Iron-Regulatory Protein Activities in Vivo
Meyron‐Holtz, E. G., Ghosh, M. C., & Rouault, T. A. (2004) · Science · doi:10.1126/science.1103786 · Cited by 246 · see citing works
Hypoxia-inducible factor-1 in human breast and prostate cancer
Kimbro, K. S., & Simons, J. W. (2006) · Endocrine Related Cancer · doi:10.1677/erc.1.00728 · Cited by 246 · see citing works
Xue, X., Ramakrishnan, S. K., Weisz, K. M., Triner, D. A., Xie, L., Attili, D., Pant, A., Győrffy, B., Zhan, M., Carter‐Su, C., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.07.015 · Cited by 242 · see citing works
Song, S.-N. J., Tomosugi, N., Kawabata, H., Ishikawa, T., Nishikawa, T., & Yoshizaki, K. (2010) · Blood · doi:10.1182/blood-2010-03-271791 · Cited by 228 · cited 5× · see citing works
“Efficacy and long-term safety of intravenous iron formulations for the treatment of AOC are still under debate and should be evaluated in prospective RCTs.”
MethodInfluentialLuo, W., Chang, R., Zhong, J., Pandey, A., & Semenza, G. L. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1217394109 · Cited by 228 · see citing works
Modulation of iron transport proteins in human colorectal carcinogenesis
Brookes, M. J., Hughes, S., Turner, F. E., Reynolds, G., Sharma, N., Ismail, T., Berx, G., McKie, A. T., Hotchin, N., Anderson, G. J., et al. (2006) · Gut · doi:10.1136/gut.2006.094060 · Cited by 226 · see citing works
Gao, J., & Richardson, D. R. (2001) · Blood · doi:10.1182/blood.v98.3.842 · Cited by 224 · see citing works
TIM-2 is expressed on B cells and in liver and kidney and is a receptor for H-ferritin endocytosis
Chen, T. T., Li, L., Chung, D.-H., Allen, C. D. C., Torti, S. V., Torti, F. M., Cyster, J. G., Chen, C.-Y., Brodsky, F. M., Niemi, E. C., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042433 · Cited by 219 · see citing works
Endothelial cells produce bone morphogenetic protein 6 required for iron homeostasis in mice
Canali, S., Zumbrennen‐Bullough, K. B., Core, A. B., Wang, C., Nairz, M., Bouley, R., Świrski, F. K., & Babitt, J. L. (2016) · Blood · doi:10.1182/blood-2016-06-721571 · Cited by 214 · see citing works
Self-citationIannetti, A., Pacifico, F., Acquaviva, R., Lavorgna, A., Crescenzi, E., Vascotto, C., Tell, G., Salzano, A. M., Scaloni, A., Vuttariello, E., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710846105 · Cited by 210 · see citing works
Dai, J., Keller, J. M., Zhang, J., Lü, Y., Yao, Z., & Keller, E. T. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1891 · Cited by 208 · see citing works
Libregts, S. F., Gutiérrez, L., de Bruin, A. M., Wensveen, F. M., Papadopoulos, P., van Ijcken, W., Özgür, Z., Philipsen, S., & Nolte, M. A. (2011) · Blood · doi:10.1182/blood-2010-10-315218 · Cited by 204 · see citing works
An iron regulatory gene signature predicts outcome in breast cancer
Miller, L. D., Coffman, L. G., Chou, J. W., Black, M. A., Bergh, J., D'Agostino, R., Torti, S. V., & Torti, F. M. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1870 · Cited by 202 · see citing works
Haabeth, O. A. W., Tveita, A. A., Fauskanger, M., Schjesvold, F. H., Lorvik, K. B., Hofgaard, P. O., Omholt, H., Munthe, L. A., Dembić, Z., Corthay, A., et al. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00174 · Cited by 199 · see citing works
Aapro, M., Österborg, A., Gascón, P., Ludwig, H., & Beguin, Y. P. (2012) · Annals of Oncology · doi:10.1093/annonc/mds112 · Cited by 198 · see citing works
Egeblad, M., Ewald, A. J., Askautrud, H. A., Truitt, M., Welm, B. E., Bainbridge, E. D., Peeters, G., Krummel, M. F., & Werb, Z. (2008) · Disease Models & Mechanisms · doi:10.1242/dmm.000596 · Cited by 198 · see citing works
Galy, B., Ferring-Appel, D., Kaden, S., Gröne, H.-J., & Hentze, M. W. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.006 · Cited by 195 · see citing works
He, H., Xu, J., Warren, C. M., Duan, D., Li, X., Wu, L., & Iruela‐Arispe, M. L. (2012) · Blood · doi:10.1182/blood-2012-04-422758 · Cited by 195 · see citing works
Nairz, M., Schroll, A., Moschen, A. R., Sonnweber, T., Theurl, M., Theurl, I., Taub, N., Jamnig, C., Neurauter, D., Huber, L. A., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.01.002 · Cited by 194 · see citing works
Self-citationHypoxia upregulates the histone demethylase JMJD1A via HIF-1
Wellmann, S. M., Bettkober, M., Marten, A., Seeger, K., Faigle, M., Eltzschig, H. K., & Bührer, C. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.05.150 · Cited by 193 · see citing works
Pharmacologic inhibition of hepcidin expression reverses anemia of chronic inflammation in rats
Theurl, I., Schroll, A., Sonnweber, T., Nairz, M., Theurl, M., Willenbacher, W., Eller, K., Wolf, D., Seifert, M., Sun, C. C., et al. (2011) · Blood · doi:10.1182/blood-2011-03-345066 · Cited by 189 · see citing works
Self-citationHypoxia-inducible factors link iron homeostasis and erythropoiesis
Shah, Y. M., & Xie, L. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.12.031 · Cited by 187 · see citing works
Hepcidin regulation in prostate and its disruption in prostate cancer
Tesfay, L., Clausen, K. A., Kim, J. W., Hegde, P., Wang, X., Miller, L. D., Deng, Z., Blanchette, N., Arvedson, T., Miranti, C. K., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2465 · Cited by 186 · see citing works
Overmeire, E. V., Laoui, D., Keirsse, J., Ginderachter, J. A. V., & Sarukhan, A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00127 · Cited by 182 · see citing works
Role of IL-10 for induction of anemia during inflammation
Tilg, H., Ulmer, H., Kaser, A., & Weiss, G. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.4.2204 · Cited by 181 · see citing works
“Pumping iron”—how macrophages handle iron at the systemic, microenvironmental, and cellular levels
Nairz, M., Theurl, I., Swirski, F. K., & Weiss, G. (2017) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-017-1944-8 · Cited by 178 · see citing works
Self-citationWeiss, G., Bogdan, C., & Hentze, M. W. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.1.420 · Cited by 177 · see citing works
Self-citationJayatilaka, H., Tyle, P., Chen, J. J., Kwak, M., Ju, J., Kim, H. J., Lee, J. S. H., Wu, P.-H., Gilkes, D. M., Fan, R., et al. (2017) · Nature Communications · doi:10.1038/ncomms15584 · Cited by 177 · see citing works
Ghassabeh, G. H., BAETSELIER, P. D., Brys, L., Noël, W., Ginderachter, J. A. V., Meerschaut, S., Beschin, A., Brombacher, F., & Raes, G. (2006) · Blood · doi:10.1182/blood-2005-04-1485 · Cited by 175 · see citing works
Omar, H. R., Mirsaeidi, M. S., Socias, S., Sprenker, C., Caldeira, C., Camporesi, E. M., & Mangar, D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124034 · Cited by 170 · see citing works
Fan, Z., Yu, P., Wang, Y., Wang, Y., Fu, M. L., Liu, W., Sun, Y., & Fu, Y. (2005) · Blood · doi:10.1182/blood-2005-08-3485 · Cited by 169 · see citing works
Iron Overload Alters Innate and T Helper Cell Responses to<i>Candida albicans</i>in Mice
Mencacci, A., Cenci, E., Boelaert, J. R., Bucci, P., Mosci, P., d'Ostiani, C. F., Bistoni, F., & Romani, L. (1997) · The Journal of Infectious Diseases · doi:10.1086/516481 · Cited by 169 · see citing works
Shah, Y. M., Ito, S., Morimura, K., Chen, C., Yim, S., Haase, V. H., & Gonzalez, F. J. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.009 · Cited by 168 · see citing works
Iron induces anti-tumor activity in tumor-associated macrophages
Costa da Silva, M., Breckwoldt, M. O., Vinchi, F., Correia, M. P., Stojanovic, A., Thielmann, C. M., Meister, M., Muley, T., Warth, A., Platten, M., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01479 · Cited by 164 · see citing works
The Roles of Jumonji-Type Oxygenases in Human Disease
Johansson, C., Tumber, A., Che, K., Cain, P., Nowak, R. P., Gileadi, C., & Oppermann, U. C. T. (2014) · Epigenomics · doi:10.2217/epi.13.79 · Cited by 163 · see citing works
The role of the IL-22/IL-22R1 axis in cancer
Lim, C., & Savan, R. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.04.005 · Cited by 162 · see citing works
Signaling Role of Intracellular Iron in NF-κB Activation
Xiong, S., She, H., Takeuchi, H., Han, B., Engelhardt, J. F., Barton, C. H., Zandi, E., Giulivi, C., & Tsukamoto, H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210905200 · Cited by 161 · see citing works
The pleiotropic effects of erythropoietin in infection and inflammation
Nairz, M., Sonnweber, T., Schroll, A., Theurl, I., & Weiss, G. (2012) · Microbes and Infection · doi:10.1016/j.micinf.2011.10.005 · Cited by 161 · see citing works
Self-citationModification of iron regulation by the inflammatory response
WEISS, G. (2005) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2004.09.001 · Cited by 161 · see citing works
Self-citationCasanovas, G., Mleczko-Sanecka, K., Altamura, S., Hentze, M. W., & Muckenthaler, M. U. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0447-2 · Cited by 161 · see citing works
Ca2+ channel blockers reverse iron overload by a new mechanism via divalent metal transporter-1
Ludwiczek, S., Theurl, I., Muckenthaler, M. U., Jakab, M., Mair, S. M., Theurl, M., Kiss, J., Paulmichl, M., Hentze, M. W., Ritter, M., et al. (2007) · Nature Medicine · doi:10.1038/nm1542 · Cited by 160 · see citing works
Neopterin, a prognostic marker in human malignancies
Sucher, R., Schroecksnadel, K., Weiß, G., Margreiter, R., Fuchs, D., & Brandacher, G. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.05.008 · Cited by 160 · see citing works
Iron nutrition and tumor growth: decreased tumor growth in iron-deficient mice.
Hann, H. W., Stahlhut, M. W., & Blumberg, B. S. (1988) · PubMed · Cited by 157 · see citing works
Erythropoietin induces tumor regression and antitumor immune responses in murine myeloma models
Mittelman, M., Neumann, D., Peled, A., Kanter, P., & Haran‐Ghera, N. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081275298 · Cited by 157 · see citing works
Iron metabolism and iron supplementation in cancer patients
Ludwig, H., Evstatiev, R., Kornek, G. V., Aapro, M., Bauernhofer, T., Buxhofer‐Ausch, V., Fridrik, M., Geissler, D., Geissler, K. H., Gisslinger, H., et al. (2015) · Wiener klinische Wochenschrift · doi:10.1007/s00508-015-0842-3 · Cited by 156 · see citing works
Wang, Z., Yin, W., Zhu, L., Li, J., Yao, Y., Chen, F., Sun, M., Zhang, J., Shen, N., Song, Y., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.05.008 · Cited by 156 · see citing works
Rao, V. A., Klein, S. R., Agama, K., Toyoda, E., Adachi, N., Pommier, Y. G., & Shacter, E. B. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-1437 · Cited by 155 · see citing works
Alkhateeb, A. A., Han, B., & Connor, J. R. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2405-x · Cited by 153 · see citing works
Erythroferrone contributes to recovery from anemia of inflammation
Kautz, L., Jung, G., Nemeth, E., & Ganz, T. (2014) · Blood · doi:10.1182/blood-2014-06-584607 · Cited by 152 · see citing works
Nairz, M., Theurl, I., Wolf, D., & Weiss, G. (2016) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-016-0505-7 · Cited by 152 · see citing works
Self-citationMeans, R. T., & Krantz, S. B. (1991) · Blood · doi:10.1182/blood.v78.10.2564.2564 · Cited by 151 · see citing works
IL-1β-Specific Up-Regulation of Neutrophil Gelatinase-Associated Lipocalin Is Controlled by IκB-ζ
Cowland, J. B., Muta, T., & Borregaard, N. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.9.5559 · Cited by 151 · see citing works
Tissue-resident versus monocyte-derived macrophages in the tumor microenvironment
Lahmar, Q., Keirsse, J., Laoui, D., Movahedi, K., Overmeire, E. V., & Ginderachter, J. A. V. (2015) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.06.009 · Cited by 151 · see citing works
Interferon‐γ limits the availability of iron for intramacrophage <i>Salmonella typhimurium</i>
Nairz, M., Fritsche, G., Brunner, P., Talasz, H., Hantke, K., & Weiss, G. (2008) · European Journal of Immunology · doi:10.1002/eji.200738056 · Cited by 151 · see citing works
Self-citationHeparin: a potent inhibitor of hepcidin expression in vitro and in vivo
Poli, M., Girelli, D., Campostrini, N., Maccarinelli, F., Finazzi, D., Luscieti, S., Nai, A., & Arosio, P. (2011) · Blood · doi:10.1182/blood-2010-06-289082 · Cited by 148 · see citing works
Nairz, M., Theurl, I., Schroll, A., Theurl, M., Fritsche, G., Lindner, E., Seifert, M., Crouch, M.-L. V., Hantke, K., Akira, S., et al. (2009) · Blood · doi:10.1182/blood-2009-05-223354 · Cited by 146 · see citing works
Self-citationKarlsen, J. R., Borregaard, N., & Cowland, J. B. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.017129 · Cited by 146 · see citing works
Anaemia in inflammatory rheumatic diseases
Weiss, G., & Schett, G. (2013) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.183 · Cited by 146 · see citing works
Xue, X., Taylor, M. J., Anderson, E. R., Hao, C., Qu, A., Greenson, J. K., Zimmermann, E. M., Gonzalez, F. J., & Shah, Y. M. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3836 · Cited by 146 · see citing works
Hypoxia induced downregulation of hepcidin is mediated by platelet derived growth factor BB
Sonnweber, T., Nachbaur, D., Schroll, A., Nairz, M., Seifert, M., Demetz, E., Haschka, D., Mitterstiller, A.-M., Kleinsasser, A., Burtscher, M., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-305317 · Cited by 145 · see citing works
Self-citationHypoxia-independent activation of HIF-1 by enterobacteriaceae and their siderophores
Hartmann, H., Eltzschig, H. K., Wurz, H., Hantke, K., Rakin, A., Yazdi, A. S., Matteoli, G., Bohn, E., Autenrieth, I. B., Karhausen, J., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.12.008 · Cited by 143 · see citing works
Heme drives hemolysis-induced susceptibility to infection via disruption of phagocyte functions
Martins, R., Maier, J., Gorki, A.-D., Huber, K. V. M., Sharif, O., Starkl, P., Saluzzo, S., Quattrone, F., Gawish, R., Lakovits, K., et al. (2016) · Nature Immunology · doi:10.1038/ni.3590 · Cited by 142 · see citing works
Dolznig, H., Habermann, B. H., Stangl, K., Deiner, E. M., Moriggl, R., Beug, H., & Müllner, E. W. (2002) · Current Biology · doi:10.1016/s0960-9822(02)00930-2 · Cited by 141 · see citing works
Porto, G. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i35.4707 · Cited by 140 · see citing works
A role for iron in Wnt signalling
Brookes, M. J., Boult, J., Roberts, K., Cooper, B. T., Hotchin, N. A., Matthews, G., Iqbal, T., & Tselepis, C. (2008) · Oncogene · doi:10.1038/sj.onc.1210711 · Cited by 139 · see citing works
Flagged first, then by citations
7 of the 423 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Cancer therapy with iron oxide nanoparticles: Agents of thermal and immune therapies
Soetaert, F., Korangath, P. C., Serantes, D., Fiering, S., & Ivkov, R. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.025 · Cited by 413 · see citing works
Altered Iron Metabolism and Impact in Cancer Biology, Metastasis, and Immunology
Brown, R. A. M., Richardson, K. L., Kabir, T. D., Trinder, D., Ganß, R., & Leedman, P. J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00476 · Cited by 279 · see citing works
Iron as a central player and promising target in cancer progression
Jung, M., Mertens, C., Tomat, E., & Brüne, B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020273 · Cited by 268 · see citing works
Repurposing ferumoxytol: Diagnostic and therapeutic applications of an FDA-approved nanoparticle
Huang, Y., Hsu, J. C., Koo, H., & Cormode, D. P. (2021) · Theranostics · doi:10.7150/thno.67375 · Cited by 259 · see citing works
Ambrosone, C. B., Zirpoli, G., Hutson, A. D., McCann, W., McCann, S. E., Barlow, W. E., Kelly, K. M., Cannioto, R. A., Sucheston‐Campbell, L. E., Hershman, D. L., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.19.01203 · Cited by 249 · see citing works
High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer
Böttger, F., Vallés‐Martí, A., Cahn, L., & Jiménez, C. R. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02134-y · Cited by 216 · see citing works
Disease-associated metabolic pathways affected by heavy metals and metalloid
Haidar, Z., Fatema, K., Shoily, S. S., & Sajib, A. A. (2023) · Toxicology Reports · doi:10.1016/j.toxrep.2023.04.010 · Cited by 208 · see citing works
Ferritin: An Inflammatory Player Keeping Iron at the Core of Pathogen-Host Interactions
Moreira, A. C., Mesquita, G., & Gomes, M. S. (2020) · Microorganisms · doi:10.3390/microorganisms8040589 · Cited by 166 · see citing works
Iron Deficiency in Heart Failure: Mechanisms and Pathophysiology
Alnuwaysir, R. I. S., Hoes, M. F., van Veldhuisen, D. J., van der Meer, P., & Beverborg, N. G. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm11010125 · Cited by 170 · see citing works
Jiang, M., Qiao, M., Zhao, C., Deng, J., Li, X., & Zhou, C. (2020) · Translational Lung Cancer Research · doi:10.21037/tlcr-20-341 · Cited by 157 · see citing works
Zhou, Z., Ni, K., Deng, H., & Chen, X. S. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.006 · Cited by 139 · see citing works
The Double-Faced Role of Nitric Oxide and Reactive Oxygen Species in Solid Tumors
Mijatović, S., Savic-Radojevic, A. R., Pljesa-Ercegovac, M. S., Simic, T. P., Nicoletti, F., & Maksimović‐Ivanić, D. (2020) · Antioxidants · doi:10.3390/antiox9050374 · Cited by 125 · see citing works
Ferroptosis: Final destination for cancer?
Zeng, Y., Liu, W., Zhuo, Q., Hu, Q., Liu, M., Sun, Q., Zhang, Z., Fan, G., Xu, W., Ji, S., et al. (2020) · Cell Proliferation · doi:10.1111/cpr.12761 · Cited by 115 · see citing works
Coulton, A., Murai, J., Qian, D., Thakkar, K., Lewis, C. E., & Litchfield, K. (2024) · Nature Communications · doi:10.1038/s41467-024-49885-8 · Cited by 114 · see citing works
Ferritin self-assembly, structure, function, and biotechnological applications
Sudarev, V. V., Dolotova, S. M., Bukhalovich, S. M., Bazhenov, S. V., Ryzhykau, Y. L., Uversky, V. N., Bondarev, N. A., Osipov, S. D., Mikhailov, A. E., Kuklina, D. D., et al. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.10.126 · Cited by 106 · see citing works
Iron Metabolism in the Tumor Microenvironment—Implications for Anti-Cancer Immune Response
Sacco, A., Battaglia, A. M., Botta, C., Aversa, I., Mancuso, S., Costanzo, F. S., & Biamonte, F. (2021) · Cells · doi:10.3390/cells10020303 · Cited by 100 · see citing works
Ferroptosis in life: To be or not to be
Xu, L., Liu, Y., Chen, X., Zhong, H., & Wang, Y. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114241 · Cited by 98 · see citing works
Green synthesis of iron nanoparticles: Sources and multifarious biotechnological applications
Kumar, V., Kaushik, N. K., Tiwari, S. K., Singh, D., & Singh, B. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.127017 · Cited by 102 · see citing works
Yeoh, Y. K., Chen, Z., Wong, M. C. S., Hui, M., Yu, J., Ng, S. C., Sung, J. J. �., Chan, F. K. L., & Chan, P. K. S. (2020) · Gut · doi:10.1136/gutjnl-2019-319635 · Cited by 74 · see citing works
The role of iron homeostasis and iron-mediated ROS in cancer.
Ying, J., Lu, Z.-B., Fu, L., Tong, Y., Wang, Z., Li, W., & Mou, X. (2021) · PubMed Central · Cited by 74 · see citing works
Flipside of the Coin: Iron Deficiency and Colorectal Cancer
Aksan, A., Farrag, K., Aksan, S., Schroeder, O., & Stein, J. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.635899 · Cited by 74 · see citing works
Ferroptosis and its Role in Gastric Cancer
Gu, R., Xia, Y., Li, P., Zou, D., Lu, K., Ren, L., Zhang, H., & Sun, Z. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.860344 · Cited by 72 · see citing works
Metabolic reprogramming in the immunosuppression of tumor-associated macrophages
Wang, Y., Wang, D., Yang, L., & Zhang, Y. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002426 · Cited by 66 · see citing works
Targetting ferroptosis for blood cell-related diseases
Chen, Z., Jiang, J., Fu, N., & Chen, L. (2021) · Journal of drug targeting · doi:10.1080/1061186x.2021.1971237 · Cited by 63 · see citing works
Chen, P., Wang, D., Xiao, T., Gu, W., Yang, H., Yang, M., & Wang, H. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110629 · Cited by 60 · see citing works
Nanomaterial-Based Repurposing of Macrophage Metabolism and Its Applications
Meng, T., He, D., Han, Z., Shi, R., Wang, Y., Ren, B., Zhang, C., Mao, Z., Luo, G., & Deng, J. (2024) · Nano-Micro Letters · doi:10.1007/s40820-024-01455-9 · Cited by 63 · see citing works
Iron metabolism in colorectal cancer: a balancing act
Estêvão, D., da Cruz-Ribeiro, M., Cardoso, A. P., Costa, Â. M., Oliveira, M. J., Duarte, T. L., & Cruz, T. (2023) · Cellular Oncology · doi:10.1007/s13402-023-00828-3 · Cited by 54 · see citing works
Formulation and evaluation of transdermal nanogel for delivery of artemether
Nnamani, P. O., Ugwu, A. A., Nnadi, O. H., Kenechukwu, F. C., Ofokansi, K. C., Attama, A. A., & Lehr, C. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-00951-4 · Cited by 53 · see citing works
Ferroptosis-mediated immune responses in cancer
Qi, D., & Peng, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1188365 · Cited by 52 · see citing works
Ferroptosis: CD8+T cells’ blade to destroy tumor cells or poison for self-destruction
Liang, Y., Zhao, Y., Li, X., Li, X., & Zhao, Y. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02415-x · Cited by 51 · see citing works
Understanding Metal Dynamics Between Cancer Cells and Macrophages: Competition or Synergism?
Serra, M., Columbano, A., Ammarah, U., Mazzone, M., & Menga, A. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00646 · Cited by 49 · see citing works
Hepcidin in hepatocellular carcinoma
Joachim, J. H., & Mehta, K. J. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01753-2 · Cited by 48 · see citing works
Li, M., Tang, Y., Wang, D., Zhai, X., Shen, H., Chen, Z., Yao, M., Jin, A., Zhou, Z., Zhou, S., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.09.012 · Cited by 44 · see citing works
Tumor Immune Evasion Induced by Dysregulation of Erythroid Progenitor Cells Development
Grzywa, T. M., Justyniarska, M., Nowis, D., & Gołąb, J. (2021) · Cancers · doi:10.3390/cancers13040870 · Cited by 41 · see citing works
Abadi, B., Yazdanpanah, N., Nokhodchi, A., & Rezaei, N. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114035 · Cited by 38 · see citing works
Ma, T., Zhou, Y., Wang, C., Wang, L., Chen, J., Yang, H., Zhang, C.-Y., Zhou, Y., & Guan, C. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/1098970 · Cited by 62 · see citing works
Leftin, A., Ben‐Chetrit, N., Joyce, J. A., & Koutcher, J. A. (2019) · Scientific Reports · doi:10.1038/s41598-018-37408-7 · Cited by 35 · see citing works
Iron deficiency in colorectal cancer patients: a cohort study on prevalence and associations
Ploug, M., Krøijer, R., Qvist, N., Lindahl, C. H., & Knudsen, T. (2020) · Colorectal Disease · doi:10.1111/codi.15467 · Cited by 34 · see citing works
Wang, M., Guo, J., Yuan, S.-J., Li, K., Zhang, Q., Lei, H.-M., Wu, J.-L., Zhao, L., Xu, Y., & Chen, X. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122913 · Cited by 33 · see citing works
Adaptive Changes Allow Targeting of Ferroptosis for Glioma Treatment
Huang, R., Dong, R., Wang, N., He, Y., Zhu, P., Wang, C., Lan, B., Gao, Y., & Sun, L. (2021) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01092-5 · Cited by 33 · see citing works
Luo, W., Dai, W., Li, Q., Mo, S., Han, L., Xiao, X., Gu, R., Xiang, W., Ye, L., Wang, R., et al. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.69808 · Cited by 33 · see citing works
Lipocalin-2: A Nurturer of Tumor Progression and a Novel Candidate for Targeted Cancer Therapy
Živalj, M., Ginderachter, J. A. V., & Stijlemans, B. (2023) · Cancers · doi:10.3390/cancers15215159 · Cited by 33 · see citing works
Iron Metabolism: State of the Art in Hypoxic Cancer Cell Biology
Liu, S., Cao, X., Wang, D., & Zhu, H. (2022) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2022.109199 · Cited by 31 · see citing works
Iron affects the sphere-forming ability of ovarian cancer cells in non-adherent culture conditions
Battaglia, A. M., Sacco, A., Vecchio, E., Scicchitano, S., Petriaggi, L., Giorgio, E., Bulotta, S., Levi, S., Faniello, M. C., Biamonte, F., et al. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1272667 · Cited by 31 · see citing works
Miao, H., Ren, Q., Li, H., Zeng, M., Chen, D. S., Xu, C., Chen, Y., & Wen, Z. (2022) · BMC Cancer · doi:10.1186/s12885-022-09314-9 · Cited by 31 · see citing works
Strategies to Interfere with Tumor Metabolism through the Interplay of Innate and Adaptive Immunity
Mora, J., Mertens, C., Meier, J. K., Fuhrmann, D. C., Brüne, B., & Jung, M. (2019) · Cells · doi:10.3390/cells8050445 · Cited by 27 · see citing works
Tumor-associated macrophages derived from cancer stem cells
Osman, A., Oze, M., Afify, S. M., Hassan, G., El‐Ghlban, S., Nawara, H. M., Fu, X., Zahra, M. H., Seno, A., Winer, I. S., et al. (2020) · Acta Histochemica · doi:10.1016/j.acthis.2020.151628 · Cited by 28 · see citing works
Mitra, A., Andrews, M. C., Roh, W., De Macedo, M. P., Hudgens, C. W., Carapeto, F., Singh, S., Reuben, A., Wang, F., Mao, X., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15538-9 · Cited by 27 · see citing works
Non-invasive assessment of normal and impaired iron homeostasis in the brain
Filo, S., Shaharabani, R., Hanin, D. B., Adam, M., Ben-David, E., Schoffman, H., Margalit, N. S., Habib, N., Shahar, T., & Mezer, A. (2023) · Nature Communications · doi:10.1038/s41467-023-40999-z · Cited by 27 · see citing works
Iron Metabolism in Liver Cancer Stem Cells
Recalcati, S., Correnti, M., Gammella, E., Raggi, C., Invernizzi, P., & Cairo, G. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00149 · Cited by 27 · see citing works
Nanotechnology-integrated ferroptosis inducers: a sharp sword against tumor drug resistance
Li, C., Wu, X., Zheng, C., Xu, S., Liu, Y., Qin, J., Fan, X., Ye, Y., & Fei, W. (2022) · Journal of Materials Chemistry B · doi:10.1039/d2tb01350a · Cited by 26 · see citing works
Zhan, S., Yung, M. M. H., Siu, M. K. Y., Jiao, P., Ngan, H., Chan, D. W., & Chan, K. K. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315263 · Cited by 25 · see citing works
Intravenous iron: do we adequately understand the short‐ and long‐term risks in clinical practice?
Rund, D. G. (2020) · British Journal of Haematology · doi:10.1111/bjh.17202 · Cited by 25 · see citing works
Tymoszuk, P., Nairz, M., Brigo, N., Petzer, V., Heeke, S., Kircher, B., Hermann‐Kleiter, N., Klepsch, V., Theurl, I., Weiß, G., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.584477 · Cited by 23 · see citing works
Self-citationGao, J., Zhang, Z., Liu, Y., Zhang, Z., Wang, M., Gong, A., Xia, L., Liao, X., Wang, D., & Zhu, H. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6629804 · Cited by 23 · see citing works
RetractedMertens, C., Schnetz, M., Rehwald, C., Grein, S., Elwakeel, E., Weigert, A., Brüne, B., & Jung, M. (2021) · Metabolites · doi:10.3390/metabo11030180 · Cited by 22 · see citing works
Loss of SLC46A1 decreases tumor iron content in hepatocellular carcinoma
Wang, D., Wu, H., Yang, J., Li, M., Ling, C., Gao, Z., Lu, H., Shen, H., & Tang, Y. (2022) · Hepatology Communications · doi:10.1002/hep4.2031 · Cited by 21 · see citing works
Kang, D. Y., Park, S., Song, K. S., Bae, S. W., Lee, J., Jang, K., & Park, Y. (2023) · Cells · doi:10.3390/cells12222628 · Cited by 21 · see citing works
Ferritin as an Effective Prognostic Factor and Potential Cancer Biomarker
Szymulewska-Konopko, K., Reszeć-Giełażyn, J., & Małeczek, M. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47010060 · Cited by 20 · see citing works
The Ferroxidase Hephaestin in Lung Cancer: Pathological Significance and Prognostic Value
Zacchi, P., Belmonte, B., Mangogna, A., Morello, G., Scola, L., Martorana, A., & Borelli, V. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.638856 · Cited by 20 · see citing works
Piatek, M. E., Griffith, D. M., & Kavanagh, K. A. (2020) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-020-01831-x · Cited by 20 · see citing works
Krieg, S., Loosen, S. H., Krieg, A. H., Luedde, T., Roderburg, C., & Kostev, K. (2024) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-05534-z · Cited by 22 · see citing works
Porter, C. M., Haffner, M. C., Kulaç, İ., Maynard, J. P., Valle, J. A. B.-D., Isaacs, W. B., Yegnasubramanian, S., Marzo, A. M. D., & Sfanos, K. S. (2019) · American Journal Of Pathology · doi:10.1016/j.ajpath.2019.07.016 · Cited by 18 · see citing works
Battaglia, A. M., Sacco, A., Aversa, I., Santamaria, G., Palmieri, C., Botta, C., Stefano, R. D., Bitetto, M., Petriaggi, L., Giorgio, E., et al. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1208485 · Cited by 17 · see citing works
Iron inhibits glioblastoma cell migration and polarization
Shenoy, G., Kheirabadi, S., Ataie, Z., Sahu, A. P., Palsa, K., Wade, Q. W., Khunsriraksakul, C., Khristov, V., Slagle‐Webb, B., Lathia, J. D., et al. (2023) · The FASEB Journal · doi:10.1096/fj.202202157rr · Cited by 16 · see citing works
The role of ferroptosis‐related genes for overall survival prediction in breast cancer
Jin, L., Gu, Y., Zhu, Q., Li, X., & Jiang, G. (2021) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24094 · Cited by 16 · see citing works
Yung, M. M. H., Siu, M. K. Y., Ngan, H., Chan, D. W., & Chan, K. K. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126857 · Cited by 17 · see citing works
Moon, D., Kim, J., & Yoon, S. P. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10593 · Cited by 16 · see citing works
Lactoferrin—A Regulator of Iron Homeostasis and Its Implications in Cancer
Bolesławska, I., Bolesławska-Król, N., Jakubowski, K., Przysławski, J., & Drzymała-Czyż, S. (2025) · Molecules · doi:10.3390/molecules30071507 · Cited by 15 · see citing works
Inflammation Mediated Hepcidin-Ferroportin Pathway and Its Therapeutic Window in Breast Cancer
Shibabaw, T., Teferi, B., Molla, M. D., & Ayelign, B. (2020) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s276404 · Cited by 15 · see citing works
Upregulated Expression of CYBRD1 Predicts Poor Prognosis of Patients with Ovarian Cancer
Chen, R., Cao, J., Jiang, W., Wang, S., & Cheng, J. (2021) · Journal of Oncology · doi:10.1155/2021/7548406 · Cited by 14 · see citing works
Cao, X., Yi, Y., Ji, M., Liu, Y., Wang, D., & Zhu, H. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1633447 · Cited by 13 · see citing works
Article review: Brazilin as potential anticancer agent
Raptania, C. N., Zakia, S., Fahira, A. I., & Amalia, R. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1355533 · Cited by 13 · see citing works
Kuo, C., Hsieh, P., Chiu, V. J.-Y., Lan, C., & Lu, K. (2023) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2023/7736638 · Cited by 14 · see citing works
Iron deficiency downregulates ENPEP to promote angiogenesis in liver tumors
Wu, H., Sun, Y., Yang, J., Gao, Z., Shen, H., Li, M., Wang, D., & Tang, Y. (2023) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2023.109357 · Cited by 12 · see citing works
The role of heme in environmentally caused oncogenesis (review)
Pinaev, S. K. (2023) · Экология человека · doi:10.17816/humeco115234 · Cited by 11 · see citing works
Cuisiniere, T., Hajjar, R., Oliero, M., Calvé, A., Fragoso, G., Rendos, H. V., Gerkins, C., Taleb, N., Gagnon-Konamna, M., Dagbert, F., et al. (2025) · Microbiome · doi:10.1186/s40168-025-02101-1 · Cited by 11 · see citing works
Mechanism and role of ferroptosis in the development of gastric cancer
Fang, W., Yu, M., Zhu, D., & Wu, J. (2025) · Clinical and Experimental Medicine · doi:10.1007/s10238-025-01722-y · Cited by 11 · see citing works
Recent Progresses in Cancer Nanotherapeutics Design Using Artemisinins as Free Radical Precursors
Wu, Y., Zeng, Q.-P., Qi, Z., Deng, T., & Liu, F. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.00472 · Cited by 11 · see citing works
Immune Escape in Prostate Cancer
Reva, B. A., Omelchenko, T., Nair, S. S., & Tewari, A. K. (2020) · Urologic Clinics of North America · doi:10.1016/j.ucl.2020.10.004 · Cited by 11 · see citing works
Chang, M. R., Rusanov, D. A., Arakelyan, J., Alshehri, M. M., Asaturova, A. V., Kireeva, G. S., Babak, M. V., & Ang, W. H. (2022) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2022.214923 · Cited by 11 · see citing works
Wang, Y., Chen, W., Zhu, M., & Xian, L. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.692530 · Cited by 11 · see citing works
Ferroptosis in eye diseases: a systematic review
Wei, S., Li, J., Zhang, Y., Li, Y., & Wang, Y. (2024) · Eye · doi:10.1038/s41433-024-03371-z · Cited by 10 · see citing works
Li, X., Li, Y., Zhang, Y.-C., Wu, Y.-X., Guo, D., Long, D., & Liu, Z. (2021) · Disease Markers · doi:10.1155/2021/5759927 · Cited by 10 · see citing works
MR susceptibility imaging for detection of tumor-associated macrophages in glioblastoma
Nazem, A., Guiry, S., Pourfathi, M., Ware, J. B., Anderson, H., Iyer, S. K., Moon, B. F., Yi, F., Witschey, W. R. T., Rizi, R. R., et al. (2022) · Journal of Neuro-Oncology · doi:10.1007/s11060-022-03947-3 · Cited by 10 · see citing works
Bibi, K., & Shah, M. H. (2020) · Biological Trace Element Research · doi:10.1007/s12011-020-02186-9 · Cited by 10 · see citing works
Tan, Z., Zhang, L., Dai, W., Zhu, W., Wang, X., & Zhang, T. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123413 · Cited by 9 · see citing works
Ezim, O. E., & Abarikwu, S. O. (2023) · Andrologia · doi:10.1155/2023/5209480 · Cited by 9 · see citing works
Anaesthesia as an influence in tumour progression
Plücker, J. S., Wirsik, N. M., Ritter, A. S., Schmidt, T., & Weigand, M. A. (2021) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-021-02078-z · Cited by 9 · see citing works
Ferroptosis in Cancer Immunotherapy—Implications for Hepatocellular Carcinoma
Kusnick, J., Bruneau, A., Tacke, F., & Hammerich, L. (2022) · Immuno · doi:10.3390/immuno2010014 · Cited by 9 · see citing works
Sexually dimorphic impact of the iron-regulating gene, HFE, on survival in glioblastoma
Nesterova, D., Midya, V., Zacharia, B. E., Proctor, E. A., Lee, S. Y., Stetson, L. C., Lathia, J. D., Rubin, J. B., Waite, K. A., Berens, M. E., et al. (2020) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdaa001 · Cited by 8 · see citing works
Shen, D.-S., Chang, Y., Chen, K.-H., Li, L., Qu, S., & Zhu, X. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s341897 · Cited by 8 · see citing works
Ferroptosis: A potential opportunity for intervention of pre-metastatic niche
Zhuo, S., Yang, L., Chen, S., Tang, C., Li, W., Gao, Z., Feng, J., & Yang, K. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.980620 · Cited by 8 · see citing works
Modulation of the Immune Response by Deferasirox in Myelodysplastic Syndrome Patients
Votavová, H., Urbanová, Z., Kundrát, D., Merkerová, M. D., Vostrý, M., Kaisrlikova, M., Čermák, J., & Beličková, M. (2021) · Pharmaceuticals · doi:10.3390/ph14010041 · Cited by 7 · see citing works
Beyond Iron: The Roles of CD71 in the Pathophysiology of Cancer—A Comprehensive Review
Markopoulos, G. S., Simos, Y. V., Tsamis, K. I., Gartzonika, K., Peschos, D., & Lakkas, L. S. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14238265 · Cited by 6 · see citing works
Ribeiro, K. S., Karmakar, E., Park, C., Garg, R., Kung, G. P., Kadakia, I., Gopianand, J. S., Arun, T., Kisselev, O. G., & Gnana‐Prakasam, J. P. (2024) · Cells · doi:10.3390/cells13131147 · Cited by 6 · see citing works
The iron chelator deferoxamine decreases myeloma cell survival
Yang, F., Wu, Z., Dai, D., Zhang, L., Zhang, X., Zhang, X., & Xu, Y. (2021) · Journal of International Medical Research · doi:10.1177/0300060520987396 · Cited by 6 · see citing works
Szczerba, K., & Stokowa‐Sołtys, K. (2023) · Pharmaceuticals · doi:10.3390/ph16030366 · Cited by 6 · see citing works
Mentzer Index in breast cancer: Insights into anemia and tumor progression – a narrative review
Obeagu, E. I. (2025) · Medicine · doi:10.1097/md.0000000000045114 · Cited by 5 · see citing works
Iron- and erythropoietin-resistant anemia in a spontaneous breast cancer mouse model
Bregolat, N. F., Ruetten, M., Silva, M. C. D., Aboouf, M. A., Ademi, H., von Büren, N., Armbruster, J., Stirn, M., Altamura, S., Marques, O., et al. (2022) · Haematologica · doi:10.3324/haematol.2022.280732 · Cited by 5 · see citing works
- Authors
- Pfeifhofer-Obermair, C., Tymoszuk, P., Petzer, V., Weiss, G., & Nairz, M.
- Affiliations
- Innsbruck Medical University (AT)
- Corresponding author
- Nairz, Manfred
- Venue
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Published
- 2018-11-26
- Volume
- 8
- Pages
- 549-549
- ISSN
- 2234-943X (ISSN-L)
- PMC
- PMC6275298
- OpenAlex
- W2902378153
- Cited by
- 151
- References
- 423
- Citations by year
- 2026: 13 · 2025: 16 · 2024: 16 · 2023: 21 · 2022: 21 · 2021: 30 · 2020: 24 · 2019: 9
- FWCI
- 2.60
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Frontiers in Oncology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Austrian Science Fund
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Ferroptosis and cancer prognosis
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Keywords
- iron metabolism, tumor microenvironment, iron homeostasis, ferroptosis, reactive oxygen species, malignant transformation, antitumor immunity, myeloid cells, tumor-associated macrophages, iron-restricted erythropoiesis, cancer-related anemia, chronic immune activation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review